Search research articles
Contact Us
Filters
Showing results (181-190 of 349) with videos related to
Page
of 35
Sort By:
Journal of Neural Transmission. Supplementum
|
January 1, 1978
The effect of selective monoamine oxidase inhibitors, clorgyline and deprenyl, upon tissue glycogen stores and blood glucose levels
G Ismahan, H Parvez, S Parvez, et al.
Journal of Neural Transmission. Supplementum
|
June 13, 1998
Deprenyl monotherapy improves visuo-motor control in early parkinsonism
S Hocherman, G Levin, N Giladi, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies
P Riederer, M B Youdim, W Birkmayer, et al.
Journal of Pharmacological Methods
|
April 1, 1990
Angiotensin-converting enzyme activity in the isolated perfused guinea pig lung
L Mor, A Bomzon, R Frenkel, et al.
British Journal of Pharmacology
|
May 1, 1982
Rate-limiting step in the metabolism of polar and non-polar monoamines in lung and liver
R R Ben-Harari, R Peleg, M B Youdim
Parkinsonism & Related Disorders
|
July 2, 2008
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?
P Foley, M Gerlach, M B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 12, 1999
Parkinson's disease: a major hypokinetic basal ganglia disorder
J Sian, M Gerlach, M B Youdim, et al.
British Journal of Pharmacology
|
November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]
L Ambrozi, W Birkmayer, P Riederer, et al.
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease
W Birkmayer, J Knoll, P Riederer, et al.
Science (New York, N.Y.)
|
May 11, 1984
Isolated chromaffin cells from adrenal medulla contain primarily monoamine oxidase B
M B Youdim, D K Banerjee, H B Pollard
Page
of 35
Search research articles
Search
Showing results (181-190 of 349) with videos related to
Sort By:
Page
of 35
Journal of Neural Transmission. Supplementum
|
January 1, 1978
The effect of selective monoamine oxidase inhibitors, clorgyline and deprenyl, upon tissue glycogen stores and blood glucose levels
G Ismahan, H Parvez, S Parvez, et al.
Journal of Neural Transmission. Supplementum
|
June 13, 1998
Deprenyl monotherapy improves visuo-motor control in early parkinsonism
S Hocherman, G Levin, N Giladi, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studies
P Riederer, M B Youdim, W Birkmayer, et al.
Journal of Pharmacological Methods
|
April 1, 1990
Angiotensin-converting enzyme activity in the isolated perfused guinea pig lung
L Mor, A Bomzon, R Frenkel, et al.
British Journal of Pharmacology
|
May 1, 1982
Rate-limiting step in the metabolism of polar and non-polar monoamines in lung and liver
R R Ben-Harari, R Peleg, M B Youdim
Parkinsonism & Related Disorders
|
July 2, 2008
MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?
P Foley, M Gerlach, M B Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 12, 1999
Parkinson's disease: a major hypokinetic basal ganglia disorder
J Sian, M Gerlach, M B Youdim, et al.
British Journal of Pharmacology
|
November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]
L Ambrozi, W Birkmayer, P Riederer, et al.
Modern Problems of Pharmacopsychiatry
|
January 1, 1983
(-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease
W Birkmayer, J Knoll, P Riederer, et al.
Science (New York, N.Y.)
|
May 11, 1984
Isolated chromaffin cells from adrenal medulla contain primarily monoamine oxidase B
M B Youdim, D K Banerjee, H B Pollard
Page
of 35